Genomic Medicine

Medicine & Life Sciences

1. 4-hydroxy-2-nonenal 6%
2. Acute Myeloid Leukemia 13%
3. Adenocarcinoma 23%
4. Adenocarcinoma of Lung 14%
5. Allogeneic Cells 7%
6. Apoptosis 11%
7. Arabidopsis 7%
8. Atlases 17%
9. B-Lymphocytes 5%
10. Biomarkers 9%
11. Breast Neoplasms 12%
12. Carcinogenesis 16%
13. Carcinoma 6%
14. Cell Cycle 7%
15. Cell Line 11%
16. Cell Proliferation 6%
17. Chromatin 11%
18. Chromosomes 5%
19. Circulating Tumor DNA 6%
20. Clonal Evolution 5%
21. Colonic Neoplasms 6%
22. Colorectal Neoplasms 10%
23. Datasets 6%
24. Dendritic Cells 7%
25. DNA 12%
26. DNA Damage 8%
27. DNA Methylation 11%
28. Down-Regulation 6%
29. Drug Therapy 6%
30. Epigenomics 15%
31. Epithelial-Mesenchymal Transition 6%
32. Exome 7%
33. Fecal Microbiota Transplantation 6%
34. Gastrointestinal Microbiome 18%
35. Gene Expression 14%
36. Genes 38%
37. Genome 36%
38. Genomics 9%
39. Glioblastoma 27%
40. Glioma 15%
41. Graft vs Host Disease 9%
42. Growth 13%
43. Heterografts 7%
44. High-Throughput Nucleotide Sequencing 6%
45. Histones 8%
46. Immunity 7%
47. Immunotherapy 12%
48. In Vitro Techniques 7%
49. Leukemia 8%
50. Ligands 8%
51. Lung 7%
52. Lung Neoplasms 10%
53. Maintenance 7%
54. Mantle-Cell Lymphoma 7%
55. Melanocytes 6%
56. Melanoma 52%
57. Messenger RNA 7%
58. Methylation 10%
59. Microbiota 26%
60. MicroRNAs 12%
61. Mitogen-Activated Protein Kinase Kinases 8%
62. Multiple Myeloma 8%
63. Mutation 49%
64. Myelodysplastic Syndromes 6%
65. Neoplasm Genes 13%
66. Neoplasm Metastasis 18%
67. Neoplasms 100%
68. Neoplastic Stem Cells 6%
69. Neural Stem Cells 5%
70. Non-Small Cell Lung Carcinoma 9%
71. Oncogenes 13%
72. Ovarian Neoplasms 11%
73. Oxidative Phosphorylation 8%
74. Pancreatic Neoplasms 14%
75. Pharmaceutical Preparations 6%
76. Phenotype 12%
77. Phosphatidylinositol 3-Kinases 6%
78. Phosphotransferases 7%
79. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6%
80. Prostatic Neoplasms 11%
81. Proteins 19%
82. Recurrence 7%
83. Renal Cell Carcinoma 10%
84. RNA 6%
85. RNA Sequence Analysis 8%
86. Stem Cells 12%
87. Survival 15%
88. T-Cell Antigen Receptor 6%
89. T-Lymphocytes 22%
90. Telomerase 11%
91. Telomere 16%
92. Therapeutics 24%
93. Transcription Factors 6%
94. Transcriptome 6%
95. Tumor Microenvironment 10%
96. Tumor Suppressor Genes 6%
97. Up-Regulation 6%
98. Uterine Cervical Neoplasms 7%
99. Whole Exome Sequencing 7%
100. Whole Genome Sequencing 10%